1. Home
  2. XNET vs INMB Comparison

XNET vs INMB Comparison

Compare XNET & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNET
  • INMB
  • Stock Information
  • Founded
  • XNET 2003
  • INMB 2015
  • Country
  • XNET China
  • INMB United States
  • Employees
  • XNET N/A
  • INMB N/A
  • Industry
  • XNET Computer Software: Prepackaged Software
  • INMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • XNET Technology
  • INMB Health Care
  • Exchange
  • XNET Nasdaq
  • INMB Nasdaq
  • Market Cap
  • XNET 131.8M
  • INMB 112.0M
  • IPO Year
  • XNET 2014
  • INMB 2019
  • Fundamental
  • Price
  • XNET $1.99
  • INMB $4.40
  • Analyst Decision
  • XNET
  • INMB Strong Buy
  • Analyst Count
  • XNET 0
  • INMB 2
  • Target Price
  • XNET N/A
  • INMB $21.00
  • AVG Volume (30 Days)
  • XNET 156.7K
  • INMB 215.6K
  • Earning Date
  • XNET 11-14-2024
  • INMB 10-31-2024
  • Dividend Yield
  • XNET N/A
  • INMB N/A
  • EPS Growth
  • XNET 146.84
  • INMB N/A
  • EPS
  • XNET 0.23
  • INMB N/A
  • Revenue
  • XNET $359,611,000.00
  • INMB $42,000.00
  • Revenue This Year
  • XNET N/A
  • INMB N/A
  • Revenue Next Year
  • XNET N/A
  • INMB N/A
  • P/E Ratio
  • XNET $8.80
  • INMB N/A
  • Revenue Growth
  • XNET 99.13
  • INMB N/A
  • 52 Week Low
  • XNET $1.45
  • INMB $4.32
  • 52 Week High
  • XNET $2.41
  • INMB $14.74
  • Technical
  • Relative Strength Index (RSI)
  • XNET 46.71
  • INMB 37.57
  • Support Level
  • XNET $1.95
  • INMB $4.74
  • Resistance Level
  • XNET $2.10
  • INMB $5.16
  • Average True Range (ATR)
  • XNET 0.11
  • INMB 0.38
  • MACD
  • XNET -0.01
  • INMB -0.05
  • Stochastic Oscillator
  • XNET 24.01
  • INMB 5.56

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

About INMB INmune Bio Inc. Common stock

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks: